alovudine has been researched along with 18f-fluoroethyl-l-tyrosine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buck, AK; Buck, D; Drzezga, A; Förschler, A; Hemmer, B; Korn, T; Krause, BJ; Lapa, C; Nessler, S; Schuster, T; Stadelmann, C; Vollmar, P; Wester, HJ; Zimmer, C | 1 |
| Erler, J; Kjaer, A; Lassen, U; Michaelsen, SR; Nedergaard, MK; Perryman, L; Poulsen, HS; Stockhausen, MT | 1 |
| Andersson, M; Johansson, L; Leide-Svegborn, S; Mattsson, S; Minarik, D | 1 |
3 other study(ies) available for alovudine and 18f-fluoroethyl-l-tyrosine
| Article | Year |
|---|---|
18F-FDG PET detects inflammatory infiltrates in spinal cord experimental autoimmune encephalomyelitis lesions.
Topics: Animals; Cell Proliferation; Dideoxynucleosides; Encephalomyelitis, Autoimmune, Experimental; Female; Fluorodeoxyglucose F18; Inflammation; Positron-Emission Tomography; Rats; Spinal Cord; Tyrosine | 2012 |
Comparison of (18)F-FET and (18)F-FLT small animal PET for the assessment of anti-VEGF treatment response in an orthotopic model of glioblastoma.
Topics: Animals; Bevacizumab; Brain Neoplasms; Cell Transformation, Neoplastic; Dideoxynucleosides; Female; Glioblastoma; HEK293 Cells; Humans; Mice; Microvessels; Positron-Emission Tomography; Survival Analysis; Tyrosine; Vascular Endothelial Growth Factor A | 2016 |
ORGAN DOSES AND EFFECTIVE DOSE FOR FIVE PET RADIOPHARMACEUTICALS.
Topics: Carbon Isotopes; Choline; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Humans; Kinetics; Male; Phantoms, Imaging; Positron-Emission Tomography; Raclopride; Radiation Dosage; Radiometry; Radiopharmaceuticals; Software; Stochastic Processes; Tyrosine | 2016 |